Macrophages play a pivotal role in regulating inflammation and can either promote or inhibit tumor growth and metastasis. Researchers harnessed the anti-tumor potential of macrophages using Ferumoxytol (FMT) combined with the Toll-like receptor 3 (TLR3) agonist, poly (I:C) (PIC), or FP-NPs (nanoparticles composed of FMT-NH2 surface functionalized with PIC). In vitro studies revealed that these combinations synergistically inhibited B16F10 cell proliferation by inducing a tumoricidal macrophage phenotype with increased TNF-α and iNOS expression, enhanced NO secretion, and augmented phagocytosis. In vivo experiments demonstrated regression of primary melanoma and alleviation of pulmonary metastasis with elevated pro-inflammatory macrophage infiltration and upregulation of pro-inflammatory genes. FP-NPs showed enhanced anti-metastatic efficacy by steering macrophages to M1 phenotype through NF-κB signaling.
Figure 1. The combined effects of FMT and PIC on macrophage activation and tumor growth inhibition were studied using Luc/GFP Reporter Cell Line-B16F10. Cell viability, GFP fluorescence intensity, proliferation, and gene expression were analyzed in co-culture experiments with RAW 264.7 cells. The results demonstrated the potential of the FMT/PIC combination in enhancing macrophage activation and inhibiting tumor growth, contributing to the understanding of immune responses in cancer therapy. (Zhao J, et al., 2018)
1. Tumor Microenvironment Studies: Assessing Luc/GFP Reporter Cell Line-B16F10 enables real-time tracking of tumor growth and metastasis in vivo.
2. Drug Efficacy Evaluation: Evaluate therapeutic interventions by monitoring luciferase activity and GFP expression post-treatment.
3. Immunotherapy Assessment: Investigate immune response dynamics through luciferase imaging, elucidating the efficacy of immunotherapeutic approaches.
4. Metastasis Research: Study metastatic progression by tracking Luc/GFP-labeled cancer cells in various organs, providing insights into metastatic mechanisms.
5. Angiogenesis Investigations: Analyze tumor angiogenesis using Luc/GFP-labeled cells to visualize neovascularization and assess anti-angiogenic therapies.
6. Microenvironment Manipulation: Manipulate tumor microenvironment components and track changes in luciferase activity and GFP expression, elucidating their impact on tumor progression.
7. Metastatic Niche Exploration: Explore pre-metastatic niche formation and colonization dynamics through luciferase imaging of Luc/GFP-labeled cancer cells.
8. Drug Delivery Studies: Assess targeted drug delivery strategies by monitoring luciferase activity and GFP expression in tumor cells following treatment administration.
Customer Q&As
What motivated the choice of B16F10 cells for establishing the luciferase/GFP reporter cell line?
A: B16F10 cells were chosen for establishing the luciferase/GFP reporter cell line due to their relevance to melanoma research and their well-characterized genetic background. Additionally, B16F10 cells exhibit high transfection efficiency, making them suitable for stable expression studies.
How was the stability and expression level of luciferase and GFP confirmed and sustained in the B16F10 reporter cell line?
A: The stability and expression level of luciferase and GFP in the B16F10 reporter cell line were confirmed and sustained through stable transfection techniques, antibiotic selection, and validation of expression using luciferase assays and fluorescence microscopy. Regular subculture and monitoring of luciferase activity and fluorescence intensity were employed to maintain stable expression levels.
Could you provide insights into the functional characterization of luciferase and GFP expression in the B16F10 reporter cell line, considering their responsiveness to regulatory elements and involvement in cellular processes?
A: Functional characterization of luciferase and GFP expression in the B16F10 reporter cell line involved assessing their responsiveness to regulatory elements by analyzing changes in luciferase activity and fluorescence intensity in response to stimuli. Additionally, their involvement in cellular processes such as gene regulation, signaling pathways, or drug response was investigated using appropriate assays and imaging techniques.
Ask a Question
Customer Reviews
Dual Fluorescence Power
Dual fluorescence power! The Luc/GFP Reporter Cell Line in B16F10 cells illuminates research with both luciferase and GFP, offering a dynamic platform for tracking tumor growth and gene expression.
United Kingdom
08/31/2021
Consistent Brilliance
From studying metastasis to evaluating treatment responses, this cell line serves as an invaluable tool for understanding tumor biology and testing novel therapies. The Luc/GFP Reporter Cell Line consistently delivers bright signals, enabling precise monitoring and quantification of cellular events.
Streamlined Experimentation
Streamlined experimentation! Its dual-reporter system simplifies data collection and interpretation, accelerating discoveries in cancer biology and therapeutics.
Write a Review